Medtronic InSync III
This article was originally published in The Gray Sheet
Executive Summary
Latest version of the implantable heart failure pacing system for resynchronization therapy is approved by FDA, adding a "sequential bi-ventricular pacing" function and advanced patient monitoring capabilities to the original InSync pacer, approved in August 2001. The new system allows physicians to "independently program and control the sequence of contractions of the right and left sides of the heart" to improve heart performance, according to Medtronic. InSync III has been available in Europe and Canada since June 2001...